Treatment with placenta-derived mesenchymal stem cells mitigates development of bronchiolitis obliterans in a murine model

被引:20
|
作者
Zhao, Yunge [1 ]
Gillen, Jacob R. [1 ]
Harris, David A. [1 ]
Kron, Irving L. [1 ]
Murphy, Michael P. [2 ]
Lau, Christine L. [1 ]
机构
[1] Univ Virginia Hlth Syst, Div Thorac & Cardiovasc Surg, Dept Surg, Charlottesville, VA USA
[2] Indiana Univ Sch Med, Vasc & Cardiac Ctr Adult Stem Cell Therapy, Indianapolis, IN 46202 USA
来源
关键词
REGULATORY T-CELLS; ISCHEMIA-REPERFUSION INJURY; ACUTE LUNG INJURY; BONE-MARROW; PROGENITOR CELLS; TRANSPLANTATION; REPAIR; PREVENTION; DISEASE; MICE;
D O I
10.1016/j.jtcvs.2013.09.041
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Bone marrow-derived mesenchymal stem cells (MSCs) have shown therapeutic potential in acute lung injury. Recently, placenta-derived human mesenchymal stem cells (PMSCs) have shown similarities with bone marrow-derived MSCs in terms of regenerative capabilities and immunogenicity. This study investigates the hypothesis that treatment with PMSCs reduces the development of bronchiolitis obliterans in a murine heterotopic tracheal transplant model. Methods: A murine heterotopic tracheal transplant model was used to study the continuum from acute to chronic rejection. In the treatment groups, PMSCs or PMSC-conditioned medium (PMSCCM) were injected either locally or intratracheally into the allograft. Phosphate-buffered saline (PBS) or blank medium was injected in the control groups. Tracheal luminal obliteration was assessed on sections stained with hematoxylin and eosin. Infiltration of inflammatory and immune cells and epithelial progenitor cells was assessed using immunohistochemistry and densitometric analysis. Results: Compared with injection of PBS, local injection of PMSCs significantly reduced luminal obliteration at 28 days after transplantation (P.015). Intratracheal injection of PMSCs showed similar results to local injection of PMSCs compared with injection of PBS and blank medium (P.022). Tracheas treated with PMSC/PMSCCM showed protection against the loss of epithelium on day 14, with an increase in P63+CK14+ epithelial progenitor cells and Foxp3+ regulatory T cells. In addition, injection of PMSCs and PMSCCM significantly reduced the number of neutrophils and CD3+ T cells on day 14. Conclusions: This study demonstrates that treatment with PMSCs is protective against the development of bronchiolitis obliterans in an heterotopic tracheal transplant model. These results indicate that PMSCs could provide a novel therapeutic option to reduce chronic rejection after lung transplant.
引用
收藏
页码:1668 / +
页数:15
相关论文
共 50 条
  • [21] Repeated systemic administration of adipose tissue-derived mesenchymal stem cells prevents tracheal obliteration in a murine model of bronchiolitis obliterans
    Lorenzi, William
    Goncalves, Fabiany Da Costa
    Schneider, Natalia
    Silva, Everton Franco
    Visioli, Fernanda
    Paz, Ana Helena
    Saueressig, Mauricio Guidi
    BIOTECHNOLOGY LETTERS, 2017, 39 (08) : 1269 - 1277
  • [22] Autophagy Promoted Neural Differentiation of Human Placenta-derived Mesenchymal Stem Cells
    Sotthibundhu, Areechun
    Muangchan, Pattamon
    Phonchai, Ruchee
    Promjantuek, Wilasinee
    Chaicharoenaudomrung, Nipha
    Kunhorm, Phongsakorn
    Noisa, Parinya
    IN VIVO, 2021, 35 (05): : 2609 - 2620
  • [23] Hypoxia modulates cell migration and proliferation in placenta-derived mesenchymal stem cells
    Li, Li
    Jaiswal, Prashant Kumar
    Makhoul, Georges
    Jurakhan, Rishi
    Selvasandran, Kaviyanka
    Ridwan, Khalid
    Cecere, Renzo
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2017, 154 (02): : 543 - +
  • [24] Human placenta-derived cells have mesenchymal stem/progenitor cell potential
    Fukuchi, Y
    Nakajima, H
    Sugiyama, D
    Hirose, I
    Kitamura, T
    Tsuji, K
    STEM CELLS, 2004, 22 (05) : 649 - 658
  • [25] Cardioprotection by placenta-derived stromal cells in a murine myocardial infarction model
    Roy, Rajika
    Brodarac, Andreja
    Kukucka, Marian
    Kurtz, Andreas
    Becher, Peter Moritz
    Juelke, Kerstin
    Choi, Yeong-Hoon
    Pinzur, Lena
    Chajut, Ayelet
    Tschoepe, Carsten
    Stamm, Christof
    JOURNAL OF SURGICAL RESEARCH, 2013, 185 (01) : 70 - 83
  • [26] CARTILAGE REPAIR BY HUMAN PLACENTA-DERIVED MESENCHYMAL STEM CELLS AND HYALURONIC ACID HYDROGEL IN A MINIPIG MODEL
    Kim, M.
    Ha, C.
    Park, Y.
    Kim, J.
    CYTOTHERAPY, 2023, 25 (06) : S66 - S66
  • [27] Treatment of traumatic optic neuropathy using human placenta-derived mesenchymal stem cells in Asian patients
    Sung, Youngje
    Lee, Sang Min
    Park, Mira
    Choi, Hye Jeong
    Kang, Sukho
    Choi, Byung In
    Lew, Helen
    REGENERATIVE MEDICINE, 2020, 15 (10) : 2163 - 2179
  • [28] Local, Origin of Mesenchymal Cells in a Murine Orthotopic Lung Transplantation Model of Bronchiolitis Obliterans
    Mimura, Takeshi
    Walker, Natalie
    Aoki, Yoshiro
    Manning, Casey M.
    Murdock, Benjamin J.
    Myers, Jeffery L.
    Lagstein, Amir
    Osterholzer, John J.
    Lama, Vibha N.
    AMERICAN JOURNAL OF PATHOLOGY, 2015, 185 (06): : 1564 - 1574
  • [29] Bone Marrow-derived Mesenchymal Stem Cells and Chronic Allograft Disease in a Bronchiolitis Obliterans Animal Model
    Gomez de Antonio, David
    Campo-Canaveral de la Cruz, Jose Luis
    Zurita, Mercedes
    Santos, Martin
    Gonzalez Lois, Carmen
    Varela de Ugarte, Andres
    Vaquero, Jesus
    ARCHIVOS DE BRONCONEUMOLOGIA, 2020, 56 (03): : 149 - 156
  • [30] EXPRESSION ANALYSIS OF PLACENTA-SPECIFIC MICRO RNAS IN HUMAN PLACENTA-DERIVED MESENCHYMAL STEM CELLS
    Fuchi, Naoki
    Kiyonori, Miura
    Ai, Higashijima
    Yuri, Hasegawa
    Yuko, Murakami
    Li Tao-Sheng
    Hideaki, Masuzaki
    PLACENTA, 2016, 46 : 116 - 116